Clinical trial
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
NCT00007358 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00007358 |
|---|---|
| Title | Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus |
| Official title | Study of Dexamethasone in Neonatal Lupus Congenital Heart Block; PRIDE (PR Interval and Dexamethasone Evaluation) in Congenital Heart Block |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Congenital Heart Block, Neonatal Lupus, Atrioventricular Nodal Dysfunction, Myocardial Injury |
| Intervention type | Drug |
| Interventions | Dexamethasone or other corticosteroid |
| Enrollment | 150 |
| Start date | Oct 1, 2000 |
| Primary completion | Apr 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | Dec 18, 2000 |
| Last update posted | Mar 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: